Skip to content
Compare prices
Independent app profile

DoseDiary: GLP-1 dose tracking app reviewed

DoseDiary is a free progressive web app for logging GLP-1 injections, weight and side effects, built by a GLP-1 user and designed without handing your data to Apple or Google services. It covers Mounjaro, Wegovy, Ozempic, Zepbound and Saxenda, has a free tier plus an optional paid upgrade, and installs straight from your browser with no app store account.

Visit DoseDiary → Free • No app store needed
No commission, no payment

Monj receives nothing for featuring DoseDiary, and nothing if you buy the premium version. It is here because a member of the Mounjaro community shared it with us and we thought it was genuinely useful.

DoseDiary app shown on a phone, displaying the GLP-1 injection and weight tracking timeline
Written by: Nick Johnson, Independent Prescription Pricing Analyst, Medstack Ltd Checked: 28 August 2026 Next review: 28 November 2026

At a glance

FreeCore tracking, optional paid tier
Web appInstalls from the browser
5 medicinesMounjaro, Wegovy, Ozempic, Zepbound, Saxenda
Privacy-ledNo Apple or Google data handling
DoseDiary injection logging screen showing dose strength, injection site and notes

Track every injection with precision

The core of DoseDiary is injection logging. Each dose is recorded with strength, injection site, time and notes, for both single-dose pens and KwikPens. Site rotation becomes something you can see rather than something you try to remember, which matters when you are injecting weekly for a year or more.

Because injections and weight entries sit on one timeline, you can see how dose changes line up with progress instead of comparing two separate charts.

What it actually does

Injection logging

Dose strength, injection site, time and notes for every injection, covering single-dose pens and KwikPens.

Unified timeline

Injections and weight on one view, so dose changes and progress are read together rather than separately.

Side effect tracking

Logs side effects and benefits per injection, revealing over time whether a dose or site is consistently harder going.

Concentration model

Free tool estimating how medicine levels rise and fall between doses, from your data and published half-lives. A model, not a measurement.

Data import

Brings existing injection and weight history across from other trackers, so switching does not mean starting from zero.

Pattern insights

Totals, most-used injection site and a consistency score, showing habits rather than just raw numbers.

The privacy point, and why it matters here

GLP-1 tracking data is unusually sensitive: it reveals a prescription medicine, a health condition and a body-weight history in one place. DoseDiary’s developer has built it so tracking and storage are not handed off to third-party platform services. That is a meaningful design decision rather than a marketing line, though as with any app you should read its current privacy policy yourself before entering anything, since policies change and we do not audit them.

DoseDiary progress view showing weight trend alongside logged GLP-1 doses

Built by someone actually using it

DoseDiary was designed by a GLP-1 user, and it shows in the details: the app tracks the things people actually wonder about mid-treatment, like whether a particular injection site keeps causing trouble, or how consistent they have really been.

It runs as a progressive web app at dosediary.app, so it works in a browser or installs to your home screen without an app store account.

What is coming

The developer has told us these are in development. Treat them as planned rather than promised, and check the app for what has actually shipped.

  • Personalised TDEE reports saved into the timeline
  • Calorie and nutrient tracking with barcode scanning
  • Side effect pattern recognition, including timing correlations
  • Device notifications to support adherence
  • Native iOS and Android apps alongside the web version

DoseDiary or Glapp?

These are the two GLP-1 trackers we profile, and they suit different people. Neither pays us anything.

DoseDiaryGlapp
FormatProgressive web app, installs from browseriPhone and Android apps, plus web
Free tierYes, plus optional paid versionYes, plus optional Glapp Max
Standout featureConcentration model and privacy-led buildBroader wellbeing and supply tracking, reports
Best if you wantFocused dose and side effect loggingA wider picture including appetite and supply

Read our independent Glapp profile, or see every free tool we build ourselves on the Monj tools page.

Try DoseDiary

Free to use, installs from your browser, no app store account required.

Visit DoseDiary →

Common questions

Is DoseDiary free?

Yes, the core tracking is free, with an optional paid version for additional features. Monj receives no commission on either, and feature access can change, so check the app for what is currently included.

Does DoseDiary tell me what dose to take?

No. It is a tracking tool, not a clinical one. It does not prescribe, diagnose or replace your prescriber, and dose decisions should always come from the clinician who assessed you.

Can it measure how much medicine is in my body?

No. The concentration tracker is a model built from the doses you log and published half-life estimates. It is an illustration of expected levels, not a blood test, and should not be used to make dosing decisions.

Do I need to download it from an app store?

No. DoseDiary is a progressive web app, so you can use it in a browser at dosediary.app or install it directly to your device without an app store account.

Which medicines does it support?

Mounjaro, Wegovy, Ozempic, Zepbound and Saxenda, covering both tirzepatide and semaglutide treatments.

Does Monj make money from this page?

No. We take no commission for featuring DoseDiary and none from any purchase of the paid version. It is listed because we think it is useful, and we would remove it if that stopped being true.

Published by Medstack Ltd (Company No. 16439872) under our editorial and review policy. Monj does not sell, prescribe or dispense medicines and is not affiliated with DoseDiary. App features, pricing and privacy terms are set by the developer and can change without notice; always check the app itself before relying on anything described here. This page is general information, not medical advice.

Original Monj content and page structure may not be copied, republished or used to create derivative works without permission. © Medstack Ltd | Monj.co.uk | iGovy.co.uk | Ogovy.co.uk | Frayo.co.uk | All rights reserved.

Monj is an independent price comparison index operated by Medstack Ltd. We are not a pharmacy and we do not sell, prescribe, supply or dispense medicines. Listings are ranked strictly by the lowest total patient price, with alphabetical order used to break ties. No pharmacy can pay for placement, ranking or badges. Some outbound links earn a referral commission, and this never affects position or inclusion. Read the full independence statement.